Shiers, D, Bradshaw, T, Campion, J. Health inequalities and psychosis: time for action. Br J Psychiatry
2015; 207: 471–3.
Tiihonen, J, Mittendorfer-Rutz, E, Torniainen, M, Alexanderson, K, Tanskanen, A. Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study. Am J Psychiatry
Morrison, AP, Turkington, D, Pyle, M, Spencer, H, Brabban, A, Dunn, G, et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet
2014; 383: 1395–403.
Jauhar, S, McKenna, PJ, Radua, J, Fung, E, Salvador, R, Laws, KR. Cognitive–behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry
2014; 204: 20–9.
Lui, SSY, Liu, ACY, Chui, WWH, Li, Z, Geng, F, Wang, Y, et al. The nature of anhedonia and avolition in patients with first-episode schizophrenia. Psychol Med
2016; 46: 437–47.
Crump, C, Winkleby, M A, Sundquist, K, Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry
2013; 170: 324–33.